Vol 52, No 3 (2021)
Short communication
Published online: 2021-06-28
Is a leukoerythroblastic blood picture common in COVID-19-positive adults?
Acta Haematol Pol 2021;52(3):207-210.
Abstract
Not available
References
- Fauci AS, Lane HC, Redfield RR. Covid-19 — navigating the uncharted. N Engl J Med. 2020; 382(13): 1268–1269.
- Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020; 33(6): 1007–1014.
- Wadman M, Couzin-Frankel J, Kaiser J, et al. A rampage through the body. Science. 2020; 368(6489): 356–360.
- Mitra A, Dwyre DM, Schivo M, et al. Leukoerythroblastic reaction in a patient with COVID-19 infection. Am J Hematol. 2020; 95(8): 999–1000.
- Clifford GO. The clinical significance of leukoerythroblastic anemia. Med Clin North Am. 1966; 50(3): 779–790.
- Beattie JW, Withey JL. Polycythaemia, leuco-erythroblastosis, and myelosclerosis. Br Med J. 1953; 2(4833): 414–417.
- Tabares Calvache E, Tabares Calvache AD, Faulhaber GA. Systematic review about etiologic association to the leukoerythroblastic reaction. Int J Lab Hematol. 2020; 42(5): 495–500.
- Lamont RF, Sobel JD, Vaisbuch E, et al. Parvovirus B19 infection in human pregnancy. BJOG. 2011; 118(2): 175–186.
- Lee WS, Margolskee E. Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome. Blood. 2020; 136(7): 914.
- Morris SB, Schwartz NG, Patel P, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection — United Kingdom and United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(40): 1450–1456.
- Pierce CA, Preston-Hurlburt P, Dai Y, et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med. 2020; 12(564).
- Jerez J, Ernst DM. High percentage of smudge cells in a patient with COVID19: rediscovering their utility. EJHaem. 2020 [Epub ahead of print].